bimatoprost/brimonidine
/ AbbVie
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 25, 2022
Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol in Glaucoma and Ocular Hypertension in India: A Multicenter, Open-Label, Phase 3 Study.
(PubMed, Clin Ophthalmol)
- "TFC offers a beneficial therapeutic alternative for patients with glaucoma or OHT whose IOP is not sufficiently controlled with dual-combination therapy. Safety and efficacy findings support those of published studies of TFC in primary open-angle glaucoma and OHT, despite differences in study designs."
Journal • P3 data • Cardiovascular • Dry Eye Disease • Glaucoma • Ophthalmology
1 to 1
Of
1
Go to page
1